Profile
Mark Dawson served as a Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd.
and GlaxoSmithKline Pakistan Ltd.
He also held Director positions at The University of Sheffield and Irvine Bay Regeneration Co. Additionally, he was a Director, VP & Head-Global Supply Chain at ViiV Healthcare Ltd.
Dawson completed his undergraduate degree at The University of Sheffield.
Former positions of Mark Dawson
| Companies | Position | End |
|---|---|---|
| GLAXOSMITHKLINE PAKISTAN LIMITED | Director/Board Member | 2022-09-27 |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Director/Board Member | 2022-06-29 |
Irvine Bay Regeneration Co.
 Irvine Bay Regeneration Co. Miscellaneous Commercial ServicesCommercial Services Irvine Bay Regeneration Co. engages in business and economic developments that focuses on providing incentives to businesses that relocate in the enterprise area. The company was founded in 2006 and is headquartered in Saltcoats, the United Kingdom. | Director/Board Member | - |
| The University of Sheffield | Director/Board Member | - |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Director/Board Member | - |
Training of Mark Dawson
| The University of Sheffield | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GLAXOSMITHKLINE PAKISTAN LIMITED | Health Technology |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Irvine Bay Regeneration Co.
Irvine Bay Regeneration Co. Miscellaneous Commercial ServicesCommercial Services Irvine Bay Regeneration Co. engages in business and economic developments that focuses on providing incentives to businesses that relocate in the enterprise area. The company was founded in 2006 and is headquartered in Saltcoats, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Mark Dawson
